UNIGE document Scientific Article
previous document  unige:54860  next document
add to browser collection
Title

Treatment of an acute promyelocytic leukemia relapse using arsenic trioxide and all-trans-retinoic in a 6-year-old child

Authors
Judas, C
Huezo-Diaz, P
Bourquin, jP
Published in Pediatric Hematology & Oncology. 2014, vol. 31, no. 2, p. 143-148
Abstract In adult therapy, arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) are recognized as active treatment of relapsed acute promyelocytic leukemia (APL). The efficacy of this combination in pediatric APL has not yet been well established. We report the case of a 6-year-old girl with relapsed APL, with a PML-RARα mutation, treated with a combination of ATO and ATRA. Over a period of 5 months, she received in total, 75 doses of intravenous ATO and 40 doses of oral ATRA. Currently, 22 months after relapse, she is still in complete remission. Here, we describe treatment of a relapsed APL in a child with limited treatment of ATO and ATRA and review the literature.
Keywords Antineoplastic Combined Chemotherapy Protocols/therapeutic useArsenicals/administration & dosageChildFemaleHumansLeukemia, Promyelocytic, Acute/drug therapyOxides/administration & dosageRecurrenceTretinoin/administration & dosage
Identifiers
PMID: 24498972
Full text
Article (Published version) (156 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Plateforme d'oncologie et d'hématologie pédiatrique (907)
Citation
(ISO format)
ROCK, Nathalie et al. Treatment of an acute promyelocytic leukemia relapse using arsenic trioxide and all-trans-retinoic in a 6-year-old child. In: Pediatric Hematology & Oncology, 2014, vol. 31, n° 2, p. 143-148. https://archive-ouverte.unige.ch/unige:54860

259 hits

0 download

Update

Deposited on : 2015-03-27

Export document
Format :
Citation style :